Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Treatment options for children with monogenic forms of obesity.

Hainerová IA, Lebl J.

World Rev Nutr Diet. 2013;106:105-12. doi: 10.1159/000342556. Epub 2013 Feb 11. Review.

PMID:
23428688
2.

[Obesity based on mutation of genes involved in energy balance].

Hainerová I.

Cas Lek Cesk. 2007;146(3):240-5. Review. Czech.

PMID:
17419307
3.

Melanocortin-4 receptor mutations in obesity.

Santini F, Maffei M, Pelosini C, Salvetti G, Scartabelli G, Pinchera A.

Adv Clin Chem. 2009;48:95-109. Review.

PMID:
19803416
4.

[Monogenic forms of obesity: from mice to human].

Clément K.

Ann Endocrinol (Paris). 2000 Dec;61 Suppl 6:39-49. Review. French.

PMID:
11148335
5.

Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review.

Valette M, Bellisle F, Carette C, Poitou C, Dubern B, Paradis G, Hercberg S, Muzard L, Clément K, Czernichow S.

Int J Obes (Lond). 2013 Aug;37(8):1027-35. doi: 10.1038/ijo.2012.169. Epub 2012 Nov 13. Review.

PMID:
23147118
6.

Mutations in melanocortin-4 receptor and human obesity.

Tao YX.

Prog Mol Biol Transl Sci. 2009;88:173-204. doi: 10.1016/S1877-1173(09)88006-X. Epub 2009 Oct 7. Review.

PMID:
20374728
7.

[Genetic variations in energy balance regulation].

Pankov IuA.

Biomed Khim. 2010 Mar-Apr;56(2):152-67. Review. Russian.

PMID:
21341504
8.

Melanocortin 3 receptor gene and melanocortin 4 receptor gene mutations: the Asian Perspective.

Lee YS.

Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:26-31. doi: 10.1002/dmrr.2351. Review.

PMID:
23280863
9.

[Obesity caused by melanocortin-4 receptor mutations].

van den Berg L, Glorie-Docter M, van den Akker E, Delemarre-van de Waal HA.

Ned Tijdschr Geneeskd. 2012;156(32):A4548. Review. Dutch.

PMID:
22871247
10.

[Monogenic obesity in human].

Onigata K.

Nihon Rinsho. 2013 Feb;71(2):297-302. Review. Japanese.

PMID:
23631210
11.

Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity.

Tao YX.

Mol Cell Endocrinol. 2005 Jul 15;239(1-2):1-14. Review.

PMID:
15975705
12.

Melanocortin-4 receptor in energy homeostasis and obesity pathogenesis.

Hinney A, Volckmar AL, Knoll N.

Prog Mol Biol Transl Sci. 2013;114:147-91. doi: 10.1016/B978-0-12-386933-3.00005-4. Review.

PMID:
23317785
13.

[Leptin-melanocortin system, body weight regulation and obesity].

Santos M JL.

Rev Med Chil. 2009 Sep;137(9):1225-34. doi: /S0034-98872009000900014. Epub . Review. Spanish.

14.

The MC4 receptor and control of appetite.

Adan RA, Tiesjema B, Hillebrand JJ, la Fleur SE, Kas MJ, de Krom M.

Br J Pharmacol. 2006 Dec;149(7):815-27. Epub 2006 Oct 16. Review.

15.

Monogenic human obesity.

Farooqi IS.

Front Horm Res. 2008;36:1-11. doi: 10.1159/0000115333. Review.

PMID:
18230891
16.

Monogenic human obesity syndromes.

Farooqi IS, O'Rahilly S.

Recent Prog Horm Res. 2004;59:409-24. Review.

PMID:
14749512
17.

Lessons from extreme human obesity: monogenic disorders.

Ranadive SA, Vaisse C.

Endocrinol Metab Clin North Am. 2008 Sep;37(3):733-51, x. doi: 10.1016/j.ecl.2008.07.003. Review.

PMID:
18775361
18.

[Monogenic obesity - current status of molecular genetic research and clinical importance].

Aldhoon-Hainerová I, Včelák J, Zamrazilová H.

Cas Lek Cesk. 2014;153(4):200-6. Review. Czech.

PMID:
25199546
19.

The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.

Fani L, Bak S, Delhanty P, van Rossum EF, van den Akker EL.

Int J Obes (Lond). 2014 Feb;38(2):163-9. doi: 10.1038/ijo.2013.80. Epub 2013 Jun 18. Review.

PMID:
23774329
20.

The neuroendocrine circuitry controlled by POMC, MSH, and AGRP.

Biebermann H, Kühnen P, Kleinau G, Krude H.

Handb Exp Pharmacol. 2012;(209):47-75. doi: 10.1007/978-3-642-24716-3_3. Review.

PMID:
22249810
Items per page

Supplemental Content

Write to the Help Desk